Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PHAXIAM Therapeutics S.A.

Equities

PHXM

FR001400K4B1

End-of-day quote Euronext Paris
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.865 EUR -0.52% Intraday chart for PHAXIAM Therapeutics S.A. -3.21% -37.72%
Apr. 15 Phaxiam initiates trial in infective endocarditis CF
Apr. 15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PHAXIAM THERAPEUTICS S.A. Stock PHAXIAM Therapeutics S.A.
 18.73M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 23.64B -
ARGENX SE Stock argenx SE
 22.39B -
GENMAB A/S Stock Genmab A/S
 17.78B
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. Charts PHAXIAM Therapeutics S.A.
  5. Sector Chart